COVID-19 Resource Centre

ESCMID Urgent update on Omicron SARS-CoV-2 variant

ESCMID is hosting a panel discussion webinar on the Omicron variant of the SARS-CoV-2 virus on Wednesday, 22 December at 18:00 CET. Speakers include ESCMID Executive Committee members Maurizio Sanguinetti, Annelies Zinkernagel and Jesús Rodríguez-Baño as well as experts Kåre Mølbak, Marion Koopmans and Yazdan Yazdanpanah. They will be answering questions on pathology, epidemiology, diagnostics, immunity and other important factors surrounding this variant of concern that has been increasing recently. Join in the discussion live to ask them questions that pertain to you.

Read up on the panelists here.


Click this link to join the event live on Wednesday, 22 December 2021 at 18:00 CET!

Frequently Asked Questions on SARS-CoV-2 Vaccines

ESCMID Study Group for Respiratory viruses (ESGREV) has collected a panel of experts to answer some of the frequently asked questions surrounding the various COVID-19 vaccines to better guide vaccine prescribers, administrators, and recipients. This guide will be periodically updated when new data becomes available.


The document covers types and availability of different vaccines, immunity, safety, considerations for specific patient populations, and general considerations spanning the 29 questions addressed. Read it here.

2021 ESCMID Websymposia on COVID-19

ESCMID is proud to announce that a series of 5 open-access websymposia will take place on Tuesday and Thursday afternoons, starting on Tuesday, 16 February 2021.


Visit the Websymposia webpage to learn more and to register.



ESCMID COVID-19 vaccination position statement

ESCMID has released a statement addressing the society's current position on COVID-19 vaccination.

The statement can be read here.

ESCMID Conference on Corona Virus Disease (ECCVID) – Emerging threats, emerging solutions

ESCMID is very pleased to announce that it will be hosting the first virtual congress specifically dedicated to COVID-19. The ESCMID Conference on Corona Virus Disease (ECCVID) will take place online from Wednesday 23rd to Friday 25th September 2020, and will cover all aspects of COVID-19.


The conference will host multiple tracks and a dedicated Programme Committee will work to secure a full and comprehensive scientific programme to cover a range of topics surrounding this emerging threat. More information will follow as the conference draws nearer.


Stay up to date on the conference website and by following us on our social media platforms like Twitter, Facebook and LinkedIn.


We hope you will join us for this incredible experience as we explore this global challenge.


EPASG Anti COVID-19 Survey

EPASG invites you to answer a short questionnaire with the aim of evaluating your actual "standard of care" for anti COVID-19 therapy use in your country and your department. The survey will allow us to assess the different practices worldwide for participants with direct patient care.

It will take no more than 10 minutes to complete this important survey to improve COVID-19 treatment. Do not hesitate, click here to participate!


Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID Position Paper

ESCMID and EASL (The European Association for the Study of the Liver) have issued a Position Paper, providing recommendations for clinicians caring for patients with liver diseases during the current pandemic. This joint paper marks a huge collaborative effort focusing on managing patients with liver disease during the COVID-19 pandemic and strengthen the ties between our societies. This pandemic poses an enormous challenge for healthcare systems in affected areas, and the extent of chronic liver disease as a risk factor is still unclear. This paper provides some recommendations for hepatologists during this challenging time.

You can download the full paper here